Trials / Completed
CompletedNCT04760405
The TOTOM Trial: Tai Chi to Optimize Transplant Outcomes for Multiple Myeloma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Arizona · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current proposal aims to test the feasibility of immune function analysis for Tai Chi Easy (TCE) intervention in multiple myeloma (MM) patients undergoing autologous stem cell transplantation (ASCT) with concurrent exploration of health related quality of life (HRQOL).
Detailed description
The current proposal aims to test the feasibility of immune function analysis for TCE intervention in MM patients undergoing ASCT with concurrent exploration of HRQOL. The data obtained from this trial will provide supporting data for a future randomized clinical trial evaluating the impact of TCE on immune function (incidence of ASCT related infectious complications, natural killer cell phenotype and activity, and myeloma remission rate (clonal plasma cell % at day 100, minimal residual disease (MRD)), with the evaluation of efficacy on improving HRQOL during ASCT. Successful completion of this CROC project will provide necessary data to support future grant applications, in particular the feasibility of immunoassay evaluation of MM patients undergoing ASCT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Tai Chi Easy | Patients will receive two 30-minute small group training sessions (Via Zoom) within 7 days of their scheduled transplant. After the training has been completed the participant will be provided with written (via manual) and electronic (DVD, MP3 file download) materials to continue with self-direct practice throughout the duration of the study. |
Timeline
- Start date
- 2021-03-11
- Primary completion
- 2023-11-28
- Completion
- 2023-11-28
- First posted
- 2021-02-18
- Last updated
- 2024-08-16
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04760405. Inclusion in this directory is not an endorsement.